Merit Medical Systems (MMSI) Cash & Equivalents (2009 - 2026)

Merit Medical Systems' Cash & Equivalents history runs 18 years deep, the most recent figure standing at $488.1 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 23.4% year-over-year to $488.1 million; the TTM figure through Mar 2026 stood at $488.1 million (up 23.4% YoY), while the FY2025 annual figure was $446.4 million, up 18.5% from the prior year.
• Cash & Equivalents came in at $488.1 million for Q1 2026 at Merit Medical Systems, up from $446.4 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $636.7 million in Q2 2024 to a low of $51.5 million in Q3 2022.
• A 5-year average of $305.0 million and a median of $376.7 million in 2024 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents soared 905.06% in 2023 and sank 46.31% in 2025, its largest moves.
• Merit Medical Systems' Cash & Equivalents stood at $58.4 million in 2022, then jumped by 905.06% to $587.0 million in 2023, then plunged by 35.83% to $376.7 million in 2024, then increased by 18.5% to $446.4 million in 2025, then rose by 9.34% to $488.1 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $488.1 million, $446.4 million, and $392.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison